#CCR25 opens with the #TARGETprotein trial results
Is additional protein beneficial in the critically ill?
Join Lee-anne Chapple, Matthew Summers & Adam Deane to find out
Editorial from Angelique de Man
Expert panel discussion
Register at criticalcarereviews.com/meetings/ccr25
Is additional protein beneficial in the critically ill?
Join Lee-anne Chapple, Matthew Summers & Adam Deane to find out
Editorial from Angelique de Man
Expert panel discussion
Register at criticalcarereviews.com/meetings/ccr25
April 3, 2025 at 4:59 PM
#CCR25 opens with the #TARGETprotein trial results
Is additional protein beneficial in the critically ill?
Join Lee-anne Chapple, Matthew Summers & Adam Deane to find out
Editorial from Angelique de Man
Expert panel discussion
Register at criticalcarereviews.com/meetings/ccr25
Is additional protein beneficial in the critically ill?
Join Lee-anne Chapple, Matthew Summers & Adam Deane to find out
Editorial from Angelique de Man
Expert panel discussion
Register at criticalcarereviews.com/meetings/ccr25
After #TARGETPROTEIN and #TTM2 biomarker results I think it's safe we need to consider the addition of biomarker sub studies into RCTs #CCR25
June 11, 2025 at 10:59 AM
After #TARGETPROTEIN and #TTM2 biomarker results I think it's safe we need to consider the addition of biomarker sub studies into RCTs #CCR25
Optimal TELSAM-Target Protein Linker Character is TargetProtein-Dependent https://www.biorxiv.org/content/10.1101/2025.08.29.672704v1
September 2, 2025 at 1:45 PM
Optimal TELSAM-Target Protein Linker Character is TargetProtein-Dependent https://www.biorxiv.org/content/10.1101/2025.08.29.672704v1
Optimal TELSAM-Target Protein Linker Character is TargetProtein-Dependent https://www.biorxiv.org/content/10.1101/2025.08.29.672704v1
September 2, 2025 at 1:45 PM
Optimal TELSAM-Target Protein Linker Character is TargetProtein-Dependent https://www.biorxiv.org/content/10.1101/2025.08.29.672704v1